Skip to main content
Top
Published in: Health and Quality of Life Outcomes 1/2014

Open Access 01-12-2014 | Research

Significant impairment of health-related quality of life in mainland Chinese patients with chronic hepatitis B: a cross-sectional survey with pair-matched healthy controls

Authors: Guihua Zhuang, Min Zhang, Yong Liu, Yaling Guo, Qian Wu, Kaina Zhou, Zhenhao Ji, Xiaomei Zhang

Published in: Health and Quality of Life Outcomes | Issue 1/2014

Login to get access

Abstract

Objective

Few studies have evaluated health-related quality of life (HRQoL) of patients with chronic hepatitis B (CHB) in mainland China. We aimed at characterizing the impact of CHB on HRQoL in mainland Chinese and finding out factors associated with HRQoL.

Methods

460 CHB patients (323 with CHB only, 54 with compensated cirrhosis and 83 with decompensated cirrhosis) and 460 pair-matched healthy controls were recruited in Xi’an city. They answered a structured questionnaire including the Short Form 36 version 2 (SF-36v2), the Chronic Liver Disease Questionnaire (CLDQ) (only for patients), and questions on socio-demographic and clinical characteristics. A blood sample was collected from each of patients for liver function tests. SF-36v2 scores were compared between patients and controls overall and by groups by paired-samples t-test, and CLDQ scores and paired differences of SF-36v2 scores were compared among three patient groups by one-way ANOVA or Kruskal-Wallis test. Multi-variable linear regression analyses were performed to identify determinants of HRQoL in patients.

Results

Patients, overall and by groups had significantly lower SF-36v2 scores than controls on all summaries and domains, with differences higher than the suggested minimally important difference values. Both the SF-36v2 and the CLDQ showed that HRQoL of patients with cirrhosis further deteriorated, but compensated and decompensated cirrhosis patients had similar total HRQoL impairments. The gradually increasing impairment with disease progression was confirmed only on physical components. Impaired liver function and currently taken anti-viral treatment were associated with lower HRQoL. Education attainment and annual per capita household income had a positive effect on HRQoL.

Conclusions

Mainland Chinese CHB patients suffered significant HRQoL impairment on all health dimensions, and the impairment reached a high level on mental health at initial stage of illness and increased gradually on physical health with disease progression. Attention should be paid to the reduction of patients’ treatment cost burden and the provision of early health education accompanied with proper treatments.
Appendix
Available only for authorised users
Literature
1.
go back to reference Liang X, Bi S, Yang W, Wang L, Cui G, Cui F, Zhang Y, Liu J, Gong X, Chen Y, Wang F, Zheng H, Wang F, Guo J, Jia Z, Ma J, Wang H, Luo H, Li L, Jin S, Hadler SC, Wang Y: Epidemiological serosurvey of hepatitis B in China–declining HBV prevalence due to hepatitis B vaccination. Vaccine 2009, 27: 6550–6557. 10.1016/j.vaccine.2009.08.048CrossRefPubMed Liang X, Bi S, Yang W, Wang L, Cui G, Cui F, Zhang Y, Liu J, Gong X, Chen Y, Wang F, Zheng H, Wang F, Guo J, Jia Z, Ma J, Wang H, Luo H, Li L, Jin S, Hadler SC, Wang Y: Epidemiological serosurvey of hepatitis B in China–declining HBV prevalence due to hepatitis B vaccination. Vaccine 2009, 27: 6550–6557. 10.1016/j.vaccine.2009.08.048CrossRefPubMed
2.
go back to reference Lu FM, Li T, Liu S, Zhuang H: Epidemiology and prevention of hepatitis B virus infection in China. J Viral Hepat 2010, 17(Suppl 1):4–9.CrossRefPubMed Lu FM, Li T, Liu S, Zhuang H: Epidemiology and prevention of hepatitis B virus infection in China. J Viral Hepat 2010, 17(Suppl 1):4–9.CrossRefPubMed
3.
4.
5.
go back to reference Testa MA, Simonson DC: Assesment of quality-of-life outcomes. N Engl J Med 1996, 334: 835–840. 10.1056/NEJM199603283341306CrossRefPubMed Testa MA, Simonson DC: Assesment of quality-of-life outcomes. N Engl J Med 1996, 334: 835–840. 10.1056/NEJM199603283341306CrossRefPubMed
6.
go back to reference Fayers PM, Machin D: Quality of Life: The Assessment, Analysis, and Interpretation of Patient-reported Outcomes. 2nd edition. John Wiley & Sons Ltd; 2007. ISBN: 0–470–02450-XCrossRef Fayers PM, Machin D: Quality of Life: The Assessment, Analysis, and Interpretation of Patient-reported Outcomes. 2nd edition. John Wiley & Sons Ltd; 2007. ISBN: 0–470–02450-XCrossRef
7.
go back to reference Ong SC, Mak B, Aung MO, Li SC, Lim SG: Health-related quality of life in chronic hepatitis B patients. Hepatology 2008, 47: 1108–1117. 10.1002/hep.22138CrossRefPubMed Ong SC, Mak B, Aung MO, Li SC, Lim SG: Health-related quality of life in chronic hepatitis B patients. Hepatology 2008, 47: 1108–1117. 10.1002/hep.22138CrossRefPubMed
8.
go back to reference Lam ETP, Lam CLK, Lai CL, Yuen MF, Fong DYT, So TMK: Health-related quality of life of Southern Chinese with chronic hepatitis B infection. Health Qual Life Outcomes 2009, 7: 52–61. 10.1186/1477-7525-7-52PubMedCentralCrossRefPubMed Lam ETP, Lam CLK, Lai CL, Yuen MF, Fong DYT, So TMK: Health-related quality of life of Southern Chinese with chronic hepatitis B infection. Health Qual Life Outcomes 2009, 7: 52–61. 10.1186/1477-7525-7-52PubMedCentralCrossRefPubMed
9.
go back to reference Ozkan M, Corapçioglu A, Balcioglu I, Ertekin E, Khan S, Ozdemir S, Karayün D, Unsalver BO, Kocaman N, Kaymakglu S, Köroglu G: Psychiatric morbidity and its effect on the quality of life of patients with chronic hepatitis B and hepatitis C. Int J Psychiatry Med 2006, 36: 283–297. 10.2190/D37Y-X0JY-39MJ-PVXQCrossRefPubMed Ozkan M, Corapçioglu A, Balcioglu I, Ertekin E, Khan S, Ozdemir S, Karayün D, Unsalver BO, Kocaman N, Kaymakglu S, Köroglu G: Psychiatric morbidity and its effect on the quality of life of patients with chronic hepatitis B and hepatitis C. Int J Psychiatry Med 2006, 36: 283–297. 10.2190/D37Y-X0JY-39MJ-PVXQCrossRefPubMed
10.
go back to reference Altindag A, Cadirci D, Sirmatel F: Depression and health related quality of life in non-cirrhotic chronic hepatitis B patients and hepatitis B carriers. Neurosciences (Riyadh) 2009, 14: 56–59. Altindag A, Cadirci D, Sirmatel F: Depression and health related quality of life in non-cirrhotic chronic hepatitis B patients and hepatitis B carriers. Neurosciences (Riyadh) 2009, 14: 56–59.
11.
go back to reference Bondini S, Kallman J, Dan A, Younoszai Z, Ramsey L, Nader F, Younossi ZM: Health-related quality of life in patients with chronic hepatitis B. Liver Int 2007, 27: 1119–1125. 10.1111/j.1478-3231.2007.01558.xCrossRefPubMed Bondini S, Kallman J, Dan A, Younoszai Z, Ramsey L, Nader F, Younossi ZM: Health-related quality of life in patients with chronic hepatitis B. Liver Int 2007, 27: 1119–1125. 10.1111/j.1478-3231.2007.01558.xCrossRefPubMed
12.
go back to reference Levy AR, Kowdley KV, Iloeje U, Tafesse E, Mukherjee J, Gish R, Bzowej N, Briggs AH: The impact of chronic hepatitis B on quality of life: a multinational study of utilities from infected and uninfected persons. Value Health 2008, 11: 527–538. 10.1111/j.1524-4733.2007.00297.xCrossRefPubMed Levy AR, Kowdley KV, Iloeje U, Tafesse E, Mukherjee J, Gish R, Bzowej N, Briggs AH: The impact of chronic hepatitis B on quality of life: a multinational study of utilities from infected and uninfected persons. Value Health 2008, 11: 527–538. 10.1111/j.1524-4733.2007.00297.xCrossRefPubMed
13.
go back to reference Drummond MF, Sculpher MJ, Torrance GW, O’Brien BJ, Stoddart GL: Methods for the Economic Evaluation of Health Care Programmes. 5th edition. New York: Oxford University Press; 2005. Drummond MF, Sculpher MJ, Torrance GW, O’Brien BJ, Stoddart GL: Methods for the Economic Evaluation of Health Care Programmes. 5th edition. New York: Oxford University Press; 2005.
14.
go back to reference Farkas JD, Farkas P: Liver and Gastroenterology Tests. In Basic Skills in Interpreting Laboratory Data. 4th edition. Edited by: Lee M. Bethesda: ASHP; 2009:235–244. Farkas JD, Farkas P: Liver and Gastroenterology Tests. In Basic Skills in Interpreting Laboratory Data. 4th edition. Edited by: Lee M. Bethesda: ASHP; 2009:235–244.
15.
go back to reference Maruish ME: User’s Manual for the SF-36v2 Health Survey. 3rd edition. Lincoln RI: QualityMetric Incorporated; 2011. Maruish ME: User’s Manual for the SF-36v2 Health Survey. 3rd edition. Lincoln RI: QualityMetric Incorporated; 2011.
16.
go back to reference Zhou KN, Zhang M, Wu Q, Ji ZH, Zhang XM, Zhuang GH: Reliability, validity and sensitivity of the Chinese (simple) short form 36 health survey version 2 (SF-36v2) in patients with chronic hepatitis B. J Viral Hepat 2013, 20: e47-e55. 10.1111/jvh.12030CrossRefPubMed Zhou KN, Zhang M, Wu Q, Ji ZH, Zhang XM, Zhuang GH: Reliability, validity and sensitivity of the Chinese (simple) short form 36 health survey version 2 (SF-36v2) in patients with chronic hepatitis B. J Viral Hepat 2013, 20: e47-e55. 10.1111/jvh.12030CrossRefPubMed
17.
go back to reference Brazier J, Roberts J, Deverill M: The estimation of a preference-based measure of health from the SF-36. J Health Econ 2002, 21: 271–292. 10.1016/S0167-6296(01)00130-8CrossRefPubMed Brazier J, Roberts J, Deverill M: The estimation of a preference-based measure of health from the SF-36. J Health Econ 2002, 21: 271–292. 10.1016/S0167-6296(01)00130-8CrossRefPubMed
18.
go back to reference Lam CLK, Brazier J, McGhee SM: Valuation of the SF-6D health states is feasible, acceptable, reliable, and valid in a Chinese population. Value Health 2008, 11: 295–303. 10.1111/j.1524-4733.2007.00233.xCrossRefPubMed Lam CLK, Brazier J, McGhee SM: Valuation of the SF-6D health states is feasible, acceptable, reliable, and valid in a Chinese population. Value Health 2008, 11: 295–303. 10.1111/j.1524-4733.2007.00233.xCrossRefPubMed
19.
go back to reference Younossi ZM, Guyatt G, Kiwi M, Boparai N, King D: Development of a disease specific questionnaire to measure health related quality of life in patients with chronic liver disease. Gut 1999, 45: 295–300. 10.1136/gut.45.2.295PubMedCentralCrossRefPubMed Younossi ZM, Guyatt G, Kiwi M, Boparai N, King D: Development of a disease specific questionnaire to measure health related quality of life in patients with chronic liver disease. Gut 1999, 45: 295–300. 10.1136/gut.45.2.295PubMedCentralCrossRefPubMed
20.
go back to reference Zhou KN, Zhang M, Wu Q, Ji ZH, Zhang XM, Zhuang GH: Psychometrics of chronic liver disease questionnaire in Chinese chronic hepatitis B patients. World J Gastroenterol 2013, 19: 3494–3501. 10.3748/wjg.v19.i22.3494PubMedCentralCrossRefPubMed Zhou KN, Zhang M, Wu Q, Ji ZH, Zhang XM, Zhuang GH: Psychometrics of chronic liver disease questionnaire in Chinese chronic hepatitis B patients. World J Gastroenterol 2013, 19: 3494–3501. 10.3748/wjg.v19.i22.3494PubMedCentralCrossRefPubMed
21.
go back to reference Foster GR: Hepatitis C virus infection: quality of life and side effects of treatment. J Hepatol 1999, 31(Suppl 1):250–254.CrossRefPubMed Foster GR: Hepatitis C virus infection: quality of life and side effects of treatment. J Hepatol 1999, 31(Suppl 1):250–254.CrossRefPubMed
22.
go back to reference Kang SC, Hwang SJ, Lee SH, Chang FY, Lee SD: Health-related quality of life and impact of antiviral treatment in Chinese patients with chronic hepatitis C in Taiwan. World J Gastroenterol 2005, 11: 7494–7498.CrossRefPubMed Kang SC, Hwang SJ, Lee SH, Chang FY, Lee SD: Health-related quality of life and impact of antiviral treatment in Chinese patients with chronic hepatitis C in Taiwan. World J Gastroenterol 2005, 11: 7494–7498.CrossRefPubMed
23.
go back to reference Hu M, Chen W: Assessment of total economic burden of chronic hepatitis B (CHB)-related diseases in Beijing and Guangzhou, China. Value Health 2009, 12(Suppl 3):89–92.CrossRef Hu M, Chen W: Assessment of total economic burden of chronic hepatitis B (CHB)-related diseases in Beijing and Guangzhou, China. Value Health 2009, 12(Suppl 3):89–92.CrossRef
24.
go back to reference Wang Y, Jia J: Control of hepatitis B in China: prevention and treatment. Expert Rev Anti Infect Ther 2011, 9: 21–25. 10.1586/eri.10.143CrossRefPubMed Wang Y, Jia J: Control of hepatitis B in China: prevention and treatment. Expert Rev Anti Infect Ther 2011, 9: 21–25. 10.1586/eri.10.143CrossRefPubMed
Metadata
Title
Significant impairment of health-related quality of life in mainland Chinese patients with chronic hepatitis B: a cross-sectional survey with pair-matched healthy controls
Authors
Guihua Zhuang
Min Zhang
Yong Liu
Yaling Guo
Qian Wu
Kaina Zhou
Zhenhao Ji
Xiaomei Zhang
Publication date
01-12-2014
Publisher
BioMed Central
Published in
Health and Quality of Life Outcomes / Issue 1/2014
Electronic ISSN: 1477-7525
DOI
https://doi.org/10.1186/1477-7525-12-101

Other articles of this Issue 1/2014

Health and Quality of Life Outcomes 1/2014 Go to the issue